Assessment of iCare IC200 Tonometry for Measuring Intraocular Pressure During Natural Sleep in Pediatric Glaucoma Patients Under 3 Years: Minimizing Anesthesia Requirements in Clinical Assessments - Summary - MDSpire
Advertisement
Assessment of iCare IC200 Tonometry for Measuring Intraocular Pressure During Natural Sleep in Pediatric Glaucoma Patients Under 3 Years: Minimizing Anesthesia Requirements in Clinical Assessments
To assess the feasibility and reliability of measuring intraocular pressure (IOP) during natural sleep in pediatric glaucoma patients under 3 years, and to compare these measurements with those obtained under general anesthesia.
Key Findings:
Reliable IOP measurements can be obtained during natural sleep in pediatric glaucoma patients, which may enhance clinical practice.
Natural sleep IOP measurements correlate well with those obtained under anesthesia.
The use of iCare IC200 tonometer may reduce the frequency of examinations under anesthesia.
Interpretation:
The study suggests that measuring IOP during natural sleep is a feasible and reliable alternative to traditional methods, potentially minimizing the need for anesthesia in young children.
Limitations:
Small sample size of 27 patients may limit generalizability and the robustness of the findings.
No formal matching or covariate adjustment was performed for historical comparisons.
Conclusion:
Integrating natural sleep-based IOP assessments into routine pediatric glaucoma surveillance could enhance patient care by reducing anesthesia exposure, and further research is needed to validate these findings.
Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.
Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia